What are the approved age groups for tirzepatide and semaglutide (glucagon-like peptide-1 (GLP-1) receptor agonists) in patients with type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Age Approvals for Tirzepatide and Semaglutide

Semaglutide Age Approval

Semaglutide (Ozempic) is FDA-approved for adults only (18 years and older) for type 2 diabetes treatment. 1

  • The FDA drug label explicitly states: "Safety and efficacy of OZEMPIC have not been established in pediatric patients (younger than 18 years)." 1
  • No pediatric approval exists for any formulation of semaglutide (injectable or oral) for either diabetes or obesity management 1
  • The medication should be discontinued at least 2 months before planned pregnancy in women of reproductive potential due to the long washout period 1

Tirzepatide Age Approval

Tirzepatide is FDA-approved for adults only (18 years and older) for type 2 diabetes treatment. 2

  • The FDA approval in the United States specifies use "in adults with type 2 diabetes" as an adjunct to diet and exercise to improve glycemic control 2
  • No pediatric data or approval exists for tirzepatide in patients under 18 years of age 2
  • The SURPASS clinical trial program enrolled adults across a broad spectrum of type 2 diabetes, with mean age 56.6 years in SURPASS-2 3

Geriatric Considerations

Both medications are safe and effective in older adults without dose adjustment required. 1

Semaglutide in Older Adults

  • In glycemic control trials, 23.6% of semaglutide-treated patients were ≥65 years and 3.2% were ≥75 years 1
  • In the SUSTAIN-6 cardiovascular outcomes trial, 48.0% were ≥65 years and 9.6% were ≥75 years 1
  • No overall differences in safety or efficacy were detected between older and younger patients, though greater sensitivity in some older individuals cannot be ruled out 1

Tirzepatide in Older Adults

  • The SURPASS-2 trial included patients with mean age 56.6 years, demonstrating efficacy across adult age ranges 3
  • Elderly patients require more vigilant monitoring for adverse effects, including dehydration risk from gastrointestinal side effects and blood pressure changes 4

Clinical Context

Both medications lack pediatric approval despite the growing prevalence of type 2 diabetes in younger populations. 1, 2

  • The absence of pediatric data represents a significant gap in treatment options for youth-onset type 2 diabetes 1, 2
  • Adult approval is based on extensive phase 3 trial data demonstrating safety and efficacy in patients 18 years and older 2, 3
  • Age alone is not a contraindication in elderly patients, but closer monitoring is warranted for adverse effects and medication interactions 4

References

4
Guideline

Pharmacological Management of Obesity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How do I transition from Wegovy (semaglutide) to Mounjaro (tirzepatide)?
What is the equivalent dose of Zepbound (tirzepatide) for a patient taking Wegovy (semaglutide) 2.4 mg per week?
Is Zepbound (tirzepatide) suitable for weight loss in a 24-year-old female with a history of gestational diabetes and high risk for type 2 diabetes?
Are there any head-to-head clinical trials comparing tirzepatida (GIP and GLP-1 receptor agonist) with semaglutide (GLP-1 receptor agonist) 2mg as of September 2025?
How to manage a 24-year-old female patient with severe hyperglycemia and history of non-adherence to oral diabetes medications, currently on insulin, metformin, and sitagliptin, requiring justification for tirzepatide therapy?
What are the recommended lifestyle modifications and medications for managing prediabetes?
Is a Creatine Kinase-MB (CKMB) level of 6.2 considered elevated in the context of an elevated total Creatine Kinase (CK) of 546?
What are alternative antibiotics for treating diverticulitis?
What is the most likely diagnosis for a patient with jaundice, right upper quadrant tenderness, hypotension, bradycardia, confusion, leukocytosis, hyperbilirubinemia, elevated liver enzymes, and a mildly dilated common bile duct with gallstones?
What is scaption in external rotation?
Is Wegovy (semaglutide) approved for use in individuals under 18 years old?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question